• HOME
  • NEWS
    • News blog
    • Video Technology
  • ABOUT US
    • Mosaiques Group
    • Scientific advisory board
    • Vision
    • Prof. Harald Mischak
    • Dr. Agnieszka Latosinska
    • Team Mosaiques
  • RESEARCH & DEVELOPMENT
    • Technology
      • Clinical Proteomics
    • Areas
      • Cardiovascular Diseases
      • Inflammatory Diseases
      • Nephrology
      • Oncology
      • Transplantation
    • Projects
  • APPLICATIONS
    • Animal Models (rat or mice)
    • Diagnostics
    • Drug Discovery
    • Drug Evaluation
    • Personalized Medicine
  • PUBLICATIONS
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
  • PROTEOME DATABASE
PUBLICATIONS

Publications of mosaiques diagnostics GmbH

Publications in 2025 Publications in 2024 Publications in 2024 Publications in 2023 Publications in 2022 Publications in 2021 Publications in 2020 Publications in 2019 Publications in 2018 Publications in 2017 Publications in 2016 Publications in 2015 Publications in 2014 Publications in 2013 Publications in 2012 Publications in 2011 Publications in 2010 Publications in 2009 Publications in 2008 Publications in 2007 Publications in 2006 Publications in 2005 Publication in 2004 Publications in 2003

Contact Mosaiques

mosaiques diagnostics GmbH

Rotenburger Str. 20
D-30659 Hannover
Germany

Phone: +49 (0)511 55 47 44 0
Fax:      +49 (0)511 55 47 44 31

Services

Diagnostic Products

 

Scientific Articles

 

Contact

Quick Links

Areas

International Network & Partners

Technology

Projects

News

FDA issues letter of support for urinary peptide-based biomarker to detect early stage of CKD.


 NEWS BLOG


Imprint                                 Copyright © 2024

Share by: